Wave shelves ALS drug following trial setback
BioPharma Dive,
Wave Life Sciences won’t further develop one of its most advanced medicines, an experimental treatment for nerve disorders…
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD
Overview of attention for article published in Nature Communications, May 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (54th percentile)
Readers on
- mendeley
- 59 Mendeley
